Symbol
| BMP6
| contributors: mct - updated : 26-06-2013
|
HGNC name
| bone morphogenetic protein 6
|
HGNC id
| 1073
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in advanced stages of myelofibrosis | constitutional
| germinal mutation
|  
|  
|  
|
might cause iron overload with severe juvenile hemochromatosis | tumoral
|  
|  
| --over
|  
|
in prostate cancer and associated with bone forming skeletal metastasis | constitutional
|  
|  
| --low
|  
|
in RPE cells in early AMD may contribute to iron build-up in age-related macular degeneration (AMD) | constitutional
|  
|  
| --low
|  
|
decreased hepcidin levels, and increased hepatic iron | |
Susceptibility
|
to drepanocytosis with reduced gravity (increasing HBF level) |
Variant & Polymorphism
SNP
| SNP associated with paucisymptomatic drepanocyosis |
|
|
Candidate gene
Marker
| BMP6 activity could be used as a prognostic indicator in prostate, bladder and colorectal cancers | |
BMP6, NOG and SOST could be used in combination as a prognostic indicator in cancer progression | Therapy target
| | |
| despite their severe iron overload, the livers of Bmp6-deficient mice have low levels of phosphorylated Smad1, Smad5 and Smad8, and these Smads are not significantly translocated to the nucleus | |
Bmp6(-/-) mice had age-dependent retinal iron accumulation and degeneration |
|
|